, Volume 70, Issue 4, pp 1131–1141 | Cite as

Therapeutic potential of Bama miniature pig adipose stem cells induced hepatocytes in a mouse model with acute liver failure

  • Shuang Zhang
  • Zhiqiang Zhu
  • Yufeng Wang
  • Shi Liu
  • Chenqiong Zhao
  • Weijun Guan
  • Yuhua ZhaoEmail author


The role of mesenchymal stem cells (MSCs) in cellular therapy is well recognized in this work. MSCs have advantages of high proliferation, clone formation, multi-lineage differentiation and immunosuppression. Furthermore, adipose-resident MSCs (ADSCs) are extensively employed due to its advantages of abundant source, low cost and simple operation. Many researchers have emphasized the role of adipose-resident MSCs in the development of therapies for liver injury, but few attentions were paid on the use of induced functional hepatocytes. Therefore, in this work the role of adipose-resident MSCs induced functional hepatocytes was mainly investigated. The function of induced hepatocytes by ELISA and the induction rate was confirmed by flow cytometry and evaluated by experimental observations. The induced hepatocytes were firstly transplanted into CCl4-caused liver damage ICR mice by tail vein. After transplantation, both liver fibrosis and function could be improved by hepatocytes, which were examined through histology, immunofluorescence staining, serum profile and biochemical parameters levels. The production of cytokines was then compared with normal mice and injury mice to explore the therapeutic mechanisms of hepatocytes. Finally, the secretions of TGF-β1, IL-6 and IL-10 in hepatocytes transplanted mice were determined and found to be higher than that of the normal and injury mice. The hepatocytes derived from ADSCs were proven to have a great significance in the therapeutic efficacy and clinical settings of liver disease animal models.


Adipose tissue Hepatocytes Liver injury Cell therapy 



This research was funded by the National Natural Science Foundation of China (Grant No.: 31472099; 31672404), the Agricultural Science and Technology Innovation Program (ASTIP) (cxgc-ias-01) and the project National Infrastructure of Animal Germplasm Resources (2016 year).


  1. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR (2013) Underestimation of liver-related mortality in the United States. Gastroenterol 145:375–382. CrossRefGoogle Scholar
  2. Bai C, Li X, Hou L, Zhang M, Guan W, Ma Y (2013) Biological characterization of chicken mesenchymal stem/progenitor cells from umbilical cord Wharton’s Jelly. Mol Cell Biochem 376:95–102. CrossRefPubMedGoogle Scholar
  3. Carvalho AB, Quintanilha LF, Dias JV, Paredes BD, Mannheimer EG, Carvalho FG, Asensi KD, Gutfilen B, Fonseca FM, Resende CM, Rezende GF, Takiya CM, de Carvalho AC, Goldenberg RC (2008) Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 26:1307–1314. CrossRefPubMedGoogle Scholar
  4. Dhawan A, Puppi J, Hughes RD, Mitry RR (2010) Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 7:7288–7298. CrossRefGoogle Scholar
  5. Jang YO, Kim YJ, Baik SK, Kim MY, Eom YW, Cho MY, Park HJ, Park SY, Kim BR, Kim JW, Soo Kim H, Kwon SO, Choi EH, Kim YM (2014) Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. Liver Int 34:33–41. CrossRefPubMedGoogle Scholar
  6. Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, Telkabadi M, Atashi A, Honardoost M, Zali MR, Soleimani M (2009) Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial. Eur J Gastroenterol Hepatol 21:1199–1205. CrossRefPubMedGoogle Scholar
  7. Khurana S, Mukhopadhyay A (2007) Characterization of the potential subpopulation of bone marrow cells involved in the repair of injured liver tissue. Stem Cells 25:1439–1447. CrossRefPubMedGoogle Scholar
  8. Komori A, Nakamura M, Fujiwara S, Yano K, Fujioka H, Migita K, Yatsuhashi H, Ishibashi H (2007) Human intrahepatic biliary epithelial cell as a possible modulator of hepatic regeneration: Potential role of biliary epithelial cell for hepatic remodeling in vivo. Hepatol Res 37:443. CrossRefGoogle Scholar
  9. Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, Chou SH, Chen JR, Chen YP, Lee OK (2004) In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40:1275–1284. CrossRefPubMedGoogle Scholar
  10. Ma C, Liu C, Li X, Lu T, Bai C, Fan Y, Guan W, Guo Y (2017) Cryopreservation and multipotential characteristics evaluation of a novel type of mesenchymal stem cells derived from Small Tailed Han Sheep fetal lung tissue. Cryobiology 75:7–14. CrossRefPubMedGoogle Scholar
  11. Mendizabal M, Silva MO (2016) Liver transplantation in acute liver failure: a challenging scenario. World J Gastroenterol 22:1523. CrossRefGoogle Scholar
  12. Ong SH, Dai H, Leong KW (2006a) Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials 27:4087–4097. CrossRefPubMedGoogle Scholar
  13. Ong SY, Dai H, Leong KW (2006b) Hepatic differentiation potential of commercially available human mesenchymal stem cells. Tissue Eng 12:3477–3485. CrossRefPubMedGoogle Scholar
  14. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, Yarmush ML (2007) Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE 2:e941. CrossRefPubMedPubMedCentralGoogle Scholar
  15. Schueller K, Pignitter M, Somoza V (2015) Sulfated and glucuronated trans-resveratrol metabolites regulate chemokines and sirtuin-1 expression in U-937 macrophages. J Agric Food Chem 63:6535–6545.
  16. Schueller F, Roy S, Loosen SH, Alder J, Koppe C, Schneider AT, Wandrer F, Bantel H, Vucur M, Mi QS, Trautwein C, Luedde T, Roderburg C (2017) miR-223 represents a biomarker in acute and chronic liver injury. Clin Sci 131:1971–1987.
  17. Terai T, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, Uchida K, Yamasaki T, Fujii Y, Okita K, Sakaida I (2006) Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24:2292–2298. CrossRefPubMedGoogle Scholar
  18. Terry C, Hughes RD, Mitry RR, Lehec SC, Dhawan A (2007) Cryopreservation-induced nonattachmen of human hepatocytes: role of adhesion molecules. Cell Transplant 16:639–647. CrossRefPubMedGoogle Scholar
  19. Tsuji H, Miyoshi S, Ikegami Y, Hida N, Asada H, Togashi I, Suzuki J, Satake M, Nakamizo H, Tanaka M, Mori T, Segawa K, Nishiyama N, Inoue J, Makino H, Miyado K, Ogawa S, Yoshimura Y, A Umezawa (2010) Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 106:1613–1623. CrossRefPubMedGoogle Scholar
  20. Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S, Lukic ML (2010) Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity 43:255–263.
  21. Volarevic V, Arsenijevic N, Lukic ML, Stojkovic M (2011) Concise review: mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells 29:5–10. CrossRefPubMedGoogle Scholar
  22. Wei JF, Li HL, Wang SH, Li TP, Fan JF, Liang XL, Li J, Han Q, Zhu L, Fan LY, Zhao RC (2014) Let-7 enhances osteogenesis and bone formation while repressing adipogenesis of human stromal/mesenchymal stem cells by regulating HMGA2. Stem Cells Dev 23:1452–1463.
  23. Xagorari A, Siotou E, Yiangou M, Tsolaki E, Bougiouklis D, Sakkas L, Fassas A, Anagnostopoulos A (2013) Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury. Int J Clin Exp Pathol 6:831–840. ISSN 1936-2625/IJCEP1302004Google Scholar
  24. Yokoyama T, Komori A, Nakamura M, Takii Y, Kamihira T, Shimoda S, Mori T, Fujiwara S, Koyabu M, Taniguchi K, Fujioka H, Migita K, Yatsuhashi H, Ishibashi H (2006) Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4] NF-kappaB and -MAPK signaling pathways. Liver Int 26:467–476. CrossRefPubMedGoogle Scholar
  25. Zaret KS, Grompe M (2008) Generation and regeneration of cells of the liver and pancreas. Science 322:1490–1494. CrossRefPubMedPubMedCentralGoogle Scholar
  26. Zhan Y, Wang Y, Wei L, Chen H, Cong X, Fei R, Gao Y, Liu F (2006) Differentiation of hematopoietic stem cells into hepatocytes in liver fibrosis in rats. Transpl Proc 38:3082–3085. CrossRefGoogle Scholar
  27. Zhang S, Bai CY, Zheng D, Gao YH, Fan YN, Li L, Guan WJ, Ma YH (2017a) Identification and characterization of pig adipose-derived progenitor cells. Can J Vet Res 80:309–317Google Scholar
  28. Zhang X, Ding J, Gou C, Wen T, Li L, Wang X, Yang H, Liu D, Lou J, Chen D, Ren F, Li X (2017b) Qingchangligan formula attenuates the inflammatory response to protect the liver from acute failure induced by d-galactosamine/lipopolysaccharide in mice. J Ethnopharmacol 201:108–116. CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  • Shuang Zhang
    • 1
  • Zhiqiang Zhu
    • 1
  • Yufeng Wang
    • 1
  • Shi Liu
    • 1
  • Chenqiong Zhao
    • 1
  • Weijun Guan
    • 2
  • Yuhua Zhao
    • 1
    Email author
  1. 1.Research Center for Sports Scientific Experiment, Harbin Sport UniversityHarbinChina
  2. 2.Department of Animal Genetic Resources, Institute of Animal ScienceChinese Academy of Agricultural SciencesBeijingChina

Personalised recommendations